BioCentury
ARTICLE | Strategy

Takeda's discovery beachhead

February 14, 2005 8:00 AM UTC

Takeda Pharmaceutical Company Ltd. says the acquisition of protein crystallography company Syrrx Inc. will improve its discovery research efficiency while providing its first U.S. discovery research capability.

A wide variety of factors contributed to Takeda's decision to buy Syrrx, according to Tetsuo Miwa, director of the discovery research center in Takeda's pharmaceutical research division...